Uracil C-13 Uses, Dosage, Side Effects and more
Uracil C-13 is under investigation in clinical trial NCT01677338 (Phase 2 Study to Evaluate the Preliminary Performance of the C13-URA Breath Test Kit in Dyspeptic Subjects).
| Trade Name | Uracil C-13 |
| Generic | Uracil C-13 |
| Uracil C-13 Other Names | 13C-uracil, Uracil (2-13c), Uracil 2c-13, Uracil C-13, 2-, Uracil-(2-13c) |
| Type | |
| Formula | C4H4N2O2 |
| Weight | Average: 113.08 Monoisotopic: 113.030632212 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
